Cite
HARVARD Citation
Kim, S. et al. (2016). A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy. BMC cancer. 16 (1), pp. 1-11. [Online].